Skin disease external powder for comprehensively killing and inhibiting bacteria and diminishing inflammation and using method thereof to beriberi skin disease

A technology for skin diseases and medicinal powders, applied in skin diseases, antibacterial drugs, pharmaceutical formulations, etc., can solve the problems of inconsistent standards, high cost, simple components, etc., to speed up the treatment process, restore health, and have no toxic side effects. Effect

Inactive Publication Date: 2010-08-25
徐金刚
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, ZL200610021018.5 introduces "Beriberi Powder and Its Preparation Method". The problem of inconsistency, at the same time, the method of use is to soak the feet after the powder is mixed with water; ZL200610128305.6 introduces "a medicinal powder for treating beriberi". The raw materials are: metronidazole specification 0.5g / tablet requires 60-100 tablets, vitamin B1 specification 25mg / tablet requires 1200-2000 tablets, chlorpheniramine specification 10mg / tablet requires 1500-2500 tablets, boric acid 80-120g, prepare one in this way The amount of medicine used in the course of treatment is huge, and it costs a lot. At the same time, the treatment method is to put it in the shoe to sterilize, and does not directly act on the lesion; ZL200610051068.8 also introduces "smelly foot powder placed in the shoe to treat foot odor", and there is also ZL200610128305. 6 has the same defect, and there are defects that the components are too simple, the pharmacology is limited, the price of acetaminophen and caffeine is high, and it is difficult to buy it in general pharmacies
Therefore, none of the medicinal powders described in the above patents can fully sterilize and inhibit the affected area and the environment of the affected area at the same time.
Therefore, in the known technology, there is no technical revelation of an external drug powder for skin diseases that is simple to prepare, reasonable in pharmacological collocation, cheap, widely available in the raw material market, and can simultaneously carry out comprehensive sterilization, antibacterial and anti-inflammatory for the affected area and the environment in contact with the affected area. In application, there is indeed a market demand for medicinal powder with similar efficacy and its ability to cure beriberi and other skin diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a skin disease external powder for comprehensively killing and inhibiting bacteria and diminishing inflammation, which comprises the following raw materials in part by weight: 10 to 100 parts of talcpowder, 1 to 20 parts of metronidazole, 1 to 10 parts of phellodendron, 1 to 10 parts of borneol, 1 to 10 parts of menthol, 1 to 10 parts of griseofulvin, 1 to 5 parts of chloramphenicol, 1 to 5 parts of sulfamethoxazole, 1 to 5 parts of aspirin, 1 to 5 parts of alum, 1 to 3 parts of chlortrimeton and 1 to 3 parts of vitamin B1. The invention also relates to a using method of the skin disease external powder for comprehensively killing and inhibiting bacteria and diminishing inflammation to beriberi skin disease. The medicaments are effectively combined, and the effects of the medicaments are supported one another, so the skin disease external powder has the effects of comprehensively killing poison, killing and inhibiting bacteria, diminishing inflammation, relieving itching, killing pain, clearing away heat, releasing toxin, restraining sweat gland, removing sweat and deodorizing on an affected part, and simultaneously has effects of killing and inhibiting bacteria and disinfecting on the environment of the affected part so as to fulfill the aims of radically curing fungi and bacterial infection skin disease and restoring the skin.

Description

A kind of comprehensive bactericidal, antibacterial and anti-inflammatory external medicine powder for skin diseases and its application method on beriberi and skin diseases technical field The invention belongs to the technical field of medicine, and in particular relates to a powder for external use which has comprehensive bactericidal, antibacterial, anti-inflammatory, antipruritic and analgesic functions and can treat skin diseases, and also relates to the use of the powder on beriberi-type skin diseases method. Background technique Various skin inflammations and pruritus caused by fungi such as ringworm, escherichia coli, mold and bacteria, and bacteria often bring misery to patients and are prone to recurrence. The most common is the beriberi skin disease of fungal infection, which is highly contagious, has a high incidence rate and has the stubbornness of easy recurrence and difficult cure, which brings great inconvenience to people's life and work. And if not trea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/756A61K9/14A61P17/00A61P31/04A61P31/10A61P29/00A61K33/38A61K33/12A61K33/06A61K31/045A61K31/4164A61K31/343A61K31/165A61K31/635A61K31/616A61K31/4402A61K31/51
Inventor 徐金刚蒋益如
Owner 徐金刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products